Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project

Basit Öğe Kaydı
dc.authorid0000-0002-5525-8696
dc.authorid0000-0002-5133-1382
dc.authorwosidCabıoğlu, Neslihan/AAZ-1196-2020
dc.authorwosidOzcinar, Beyza/AAF-3116-2020
dc.authorwosidSaip, pınar/AAT-1500-2020
dc.authorwosidAribal, Erkin/X-6448-2018
dc.authorwosidGurdal, Sibel Ozkan/ABA-3882-2020
dc.authorwosidOzmen, Vahit/AAE-3904-2020
dc.contributor.authorÖzmen, Vahit
dc.contributor.authorGürdal, Sibel Özkan
dc.contributor.authorCabıoğlu, Neslihan
dc.contributor.authorÖzçınar, Beyza
dc.contributor.authorÖzaydın, Ayşe Nilüfer
dc.contributor.authorKayhan, Arda
dc.contributor.authorAlagöz, Oğuzhan
dc.date.accessioned2022-05-11T14:34:59Z
dc.date.available2022-05-11T14:34:59Z
dc.date.issued2017
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı
dc.description.abstractObjective: We used the results from the first three screening rounds of Bahcesehir Mammography Screening Project (BMSP), a 10-year (20092019) and the first organized population-based screening program implemented in a county of Istanbul, Turkey, to assess the potential cost-effectiveness of a population-based mammography screening program in Turkey. Materials and Methods: Two screening strategies were compared: BMSP (includes three biennial screens for women between 40-69) and Turkish National Breast Cancer Registry Program (TNBCRP) which includes no organized population-based screening. Costs were estimated using direct data from the BMSP project and the reimbursement rates of Turkish Social Security Administration. The life-years saved by BMSP were estimated using the stage distribution observed with BMSP and TNBCRP. Results: A total of 67 women (out of 7234 screened women) were diagnosed with breast cancer in BMSP. The stage distribution for AJCC stages O, I, II, III, IV was 19.4%, 50.8%, 20.9%, 7.5%, 1.5% and 4.9%, 26.6%, 44.9%, 20.8%, 2.8% with BMSP and TNBCRP, respectively. The BMSP program is expected to save 279.46 life years over TNBCRP with an additional cost of $ 677.171, which implies an incremental cost-effectiveness ratio (ICER) of $ 2.423 per saved life year. Since the ICER is smaller than the Gross Demostic Product (GDP) per capita in Turkey ($ 10.515 in 2014), BMSP program is highly cost-effective and remains cost-effective in the sensitivity analysis. Conclusion: Mammography screening may change the stage distribution of breast cancer in Turkey. Furthermore, an organized population-based screening program may be cost-effective in Turkey and in other developing countries. More research is needed to better estimate life-years saved with screening and further validate the findings of our study.
dc.description.sponsorshipRoche Turkey; Breast Health Society of Turkey (MEMEDER); Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER
dc.description.sponsorshipThe study was funded by Roche Turkey and in part by the Breast Health Society of Turkey (MEMEDER). Also, it was partially supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
dc.identifier.doi10.5152/ejbh.2017.3528
dc.identifier.endpage+
dc.identifier.issn2587-0831
dc.identifier.issue3en_US
dc.identifier.pmid28894850
dc.identifier.startpage117
dc.identifier.urihttps://doi.org/10.5152/ejbh.2017.3528
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8161
dc.identifier.volume13
dc.identifier.wosWOS:000423913500003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.institutionauthorGürdal, Sibel Özkan
dc.language.isoen
dc.publisherAves Press Ltd
dc.relation.ispartofEuropean Journal of Breast Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMammography screening
dc.subjectbreast cancer screening Turkey
dc.subjectcost-effectiveness of breast cancer screening
dc.subjectResource Countries
dc.subjectRandomized-Trials
dc.subjectWomen
dc.subjectMortality
dc.subjectSurvival
dc.titleCost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
8161.pdf
Boyut:
200.19 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Tıp Fakültesi Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu